Liminal BioSciences Inc expected to post a loss of 53 cents a share - Earnings Preview

Liminal BioSciences

13/08/2021 22:24

* Liminal BioSciences Inc  LMNL.OQ   LMNL.O  is expected
to report results on August 16 (estimated).
* The Laval, Quebec-based company is expected to report revenue
of C$226 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Liminal BioSciences Inc
is for a loss of 53 cents per share. 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Liminal
BioSciences Inc is $4​, about 35% above​ its last closing price
of $2.60. ​​​
* Previous quarterly performance (using preferred earnings
measure in Canadian dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.63       -0.63      -0.68     Missed  -7.9
 Dec. 31 2020  -0.73       -0.73      -1.45     Missed  -99.5
 Sep. 30 2020  -1.01       -1.01      -0.98     Beat    3​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 13 at 21:24 GMT.  All
figures in Canadian dollars unless otherwise stated